Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
26.93
-1.20 (-4.28%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Vor Biopharma Employees
Vor Biopharma had 159 employees as of December 31, 2024. The number of employees decreased by 9 or -5.36% compared to the previous year.
Employees
159
Change (1Y)
-9
Growth (1Y)
-5.36%
Revenue / Employee
n/a
Profits / Employee
-$10,468,088
Market Cap
184.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159 | -9 | -5.36% |
| Dec 31, 2023 | 168 | 35 | 26.32% |
| Dec 31, 2022 | 133 | -2 | -1.48% |
| Dec 31, 2021 | 135 | 47 | 53.41% |
| Dec 31, 2020 | 88 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VOR News
- 6 days ago - Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjögren's Disease - GlobeNewsWire
- 11 days ago - Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at American Society of Nephrology's Kidney Week 2025 - GlobeNewsWire
- 12 days ago - Vor Bio Announces Publication of China Phase 3 Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine - GlobeNewsWire
- 14 days ago - Telitacicept Demonstrates Clinically Meaningful and Statistically Significant Impact on ESSDAI Compared to Placebo in Late-Breaking China Phase 3 Results in Primary Sjögren's Disease at ACR 2025 - GlobeNewsWire
- 25 days ago - Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Vor Bio Announces Late-Breaking Poster Presentation of Phase 3 Primary Sjögren's Disease Clinical Study at ACR Convergence 2025 - GlobeNewsWire
- 4 weeks ago - Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise - Seeking Alpha
- 5 weeks ago - Vor Bio Appoints Navid Z. Khan, Ph.D. - GlobeNewsWire